• Cost-effective drug found to prevent hepatitis C transmission in kidney transplantation

    1 month ago - By Healio

    A short course of direct-acting anti-viral prophylaxis may be effective in preventing transmission of hepatitis C virus from kidney donors to recipients, according to study results presented virtually at the American Transplant Congress.
    Citing previous trials that indicated a 12-week course of direct-acting anti-viral drugs is effective in treating hepatitis C virus transmission from infected donors to HCV-negative recipients, Gaurav Gupta, MD, of Virginia Commonwealth University, told the audience that translating these trials into real-life practice can be challenging.
    Read more ...